You have 1 free disease view remaining today. Register for more view, it is 100% free →
retinitis pigmentosa 85
Description
Retinitis Pigmentosa (RP): A Group of Inherited Eye Diseases
Retinitis pigmentosa (RP) is a group of inherited eye diseases that cause progressive vision loss. It affects the retina, the light-sensitive layer of tissue in the back of the eye.
- Causes: RP is caused by genetic variants that affect the retina's ability to function properly.
- Symptoms:
- Initial symptoms include poor vision in dim light and peripheral vision problems.
- As the disease progresses, people may experience a constriction in their visual field, leading to "tunnel vision".
- Complete blindness is uncommon, but it can occur in advanced cases.
- Inheritance: RP often has an autosomal dominant inheritance pattern, meaning one copy of an altered gene in each cell is sufficient to cause the disorder.
- Prevalence: The condition affects approximately 1 in 4,000 people worldwide, with variable prevalence in different populations.
Key Facts
- RP is a group of inherited eye diseases that cause progressive vision loss.
- It affects the retina's ability to function properly due to genetic variants.
- Initial symptoms include poor vision in dim light and peripheral vision problems.
- As the disease progresses, people may experience a constriction in their visual field.
References
[1] Context 2: Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of inherited retinal disorders characterized by diffuse progressive dysfunction of predominantly rod photoreceptors with subsequent degeneration of cone photoreceptors and the retinal pigment epithelium (RPE). [Context 12]
[2] Context 11: RP makes cells in the retina break down slowly over time, causing vision loss. [Context 14]
[3] Context 6: Most people with autosomal dominant retinitis pigmentosa have an affected parent. [Context 13]
[4] Context 5: Initially, retinitis pigmentosa causes poor vision in dim light, and in most cases, progresses to a constriction in the visual field that can lead to tunnel vision. [Context 14]
[5] Context 12: The condition is estimated to affect 1 in 4,000 people worldwide, with variable prevalence in different populations.
Additional Characteristics
- Genetic variants affecting the retina's ability to function properly
- Poor vision in dim light and peripheral vision problems
- Constriction in visual field leading to 'tunnel vision'
- Estimated to affect 1 in 4,000 people worldwide
Signs and Symptoms
Common Signs and Symptoms of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of rare eye diseases that affect the retina, leading to progressive vision loss. The signs and symptoms of RP can vary from person to person, but here are some common ones:
- Night blindness: Difficulty seeing in dimly lit environments or at dusk, which can progress to complete loss of night vision [1, 5, 6].
- Tunnel vision: Losing peripheral vision and only being able to see a small central area [1, 7].
- Photophobia: Sensitivity to bright light, which can cause discomfort or pain in the eyes [1].
- Color blindness: Difficulty seeing colors, especially reds and greens [1].
- Low vision: Gradual loss of central vision, leading to significant visual impairment [2, 3, 4].
These symptoms usually start in childhood or adolescence but can progress at different rates for each individual. In some cases, RP may be accompanied by other conditions, such as cataracts, macular lesions, or refractive errors.
It's essential to note that there is no cure for retinitis pigmentosa, but various vision aids and rehabilitation programs can help individuals with RP make the most of their remaining vision [2].
Additional Symptoms
- Night blindness
- Color blindness
- Low vision
- Tunnel vision
- photophobia
Diagnostic Tests
Diagnostic Tests for Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a genetic disorder that affects the retina, leading to progressive vision loss. Diagnosing RP can be challenging, but several diagnostic tests can help confirm the condition.
- Electroretinogram (ERG): This is the most critical diagnostic test for RP, as it provides an objective measure of rod and cone function across the retina [4]. ERG measures the electrical activity of the retina in response to light stimuli.
- Electro-oculogram (EOG): This test measures the electrical potential between the front and back of the eye, which can help diagnose RP [3].
- Multifocal electroretinogram (mfERG): This test is similar to ERG but provides more detailed information about the function of different parts of the retina.
- Optical Coherence Tomography (OCT): OCT takes highly detailed pictures of the retina, which can help diagnose RP by showing characteristic changes in the retinal structure [5].
- Dilated eye exam: A comprehensive eye examination, including a dilated pupil, can help identify signs of RP, such as pigment deposits in the fundus.
- Genetic test: Genetic testing can confirm the presence of mutations associated with RP.
These diagnostic tests can help confirm the diagnosis of retinitis pigmentosa and rule out other conditions that may cause similar symptoms. Early diagnosis is essential for managing the condition effectively and providing appropriate treatment and support.
References: [1] Context result 2 [3] Context result 3 [4] Context result 4 [5] Context result 5
Treatment
Current Drug Treatments for Retinitis Pigmentosa
While there is no cure for retinitis pigmentosa (RP), several drug treatments are being developed and used to slow down vision loss and improve quality of life. Here are some of the current options:
- Vitamin A supplements: Vitamin A is essential for the health of the retina, and supplementing with it may help slow down vision loss in people with RP [6].
- Acetazolamide: This medication can help reduce fluid buildup in the eyes and improve vision in some people with RP [13].
- Stem cell therapy: Researchers are exploring the potential of stem cells to differentiate into photoreceptor cells and RPE cells, which could replace damaged or lost cells and restore visual function [14].
Emerging Treatments
Several emerging treatments show promise for treating RP:
- Gene therapies: Gene therapies like Luxturna (voretigene neparvovec-ryzl) have been approved by the FDA to treat specific types of RP, and other gene therapies are in development [7, 8].
- N-acetylcysteine-amide (NACA): This molecule is being developed as a treatment for RP, Usher syndrome, and related conditions [3].
Future Directions
Researchers continue to explore new treatments for RP, including:
- Retinal gene therapies: Several retinal gene therapies are in development, which aim to replace or repair damaged genes that cause RP [5].
- Optogenetics therapies: Optogenetics therapies use light to stimulate cells and restore vision, with some promising results in early trials [11].
These emerging treatments offer hope for people living with RP, but more research is needed to fully understand their potential benefits and limitations.
Recommended Medications
- Stem cell therapy
- Gene therapies
- Retinal gene therapies
- N-acetylcysteine-amide (NACA)
- Optogenetics therapies
- vitamin A
- Vitamin A
- acetazolamide
- Acetazolamide
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a rare genetic disorder that affects the retina, leading to progressive vision loss. The differential diagnosis of RP involves ruling out other conditions that may present with similar symptoms.
Conditions to Consider:
- Leber's Congenital Amaurosis: A group of inherited disorders that affect the retina and optic nerve, leading to severe visual impairment or blindness [5].
- Central Progressive Vision Loss: A condition characterized by progressive vision loss in one eye, which can be caused by various factors such as trauma, inflammation, or autoimmune diseases [3].
- Chronic Progressive Conditions: Other conditions like chloroquine and hydroxychloroquine toxicity, chronic progressive retinal degeneration, and central serous chorioretinopathy should also be considered in the differential diagnosis of RP [1].
Diagnostic Tests:
To diagnose RP accurately, several tests can be performed, including:
- Dilated Eye Examination: A comprehensive eye examination to assess the retina and optic nerve.
- Visual Field Test: To evaluate peripheral vision loss.
- Electroretinography (ERG) test: Measures the electrical activity of the retina.
- Optical Coherence Tomography (OCT) scan: Provides detailed images of the retina.
Genetic Testing:
In some cases, genetic testing may be necessary to confirm a diagnosis of RP or rule out other conditions. This can help identify specific genetic mutations that contribute to the development of RP [8].
References:
[1] May 16, 2024 — Differential Diagnoses · Best Disease · Central Serous Chorioretinopathy · Chloroquine and Hydroxychloroquine Toxicity · Chronic Progressive ...
[2] by CC Chow · Cited by 1 — In general, the diagnosis of retinitis pigmentosa is established when the following findings are present. ... Differential diagnosis.
[3] by TB O'Neal · 2023 · Cited by 116 — Differential Diagnosis. The differential diagnosis for progressive vision loss is complex. RP is a clinical diagnosis confirmed by bilateral eye involvement ...
[4] by M Nakahara · 2021 · Cited by 5 — Concentric retinitis pigmentosa (RP), in which retinal degeneration is limited in the periphery, is rare and little information exists to date ...
[5] by C Hamel · 2006 · Cited by 1257 — Differential diagnosis. Leber's congenital amaurosis (LCA), which also belongs to the group of pigmentary retinopathies, must be ...
[6] The diagnosis of RP is based on peripheral visual field loss, pigment deposits in fundus, loss of photoreceptors at the optical coherence tomography (OCT) scan ...
[7] What tests will be done to diagnose retinitis pigmentosa? · Dilated eye examination with visual field test · Electroretinography (ERG) test · Optical coherence ...
[8] Aug 29, 2024 — Genetic testing · DIFFERENTIAL DIAGNOSIS · Traumatic retinopathy · Retinal inflammatory diseases · Autoimmune paraneoplastic retinopathy · Drug ...
Additional Differential Diagnoses
- Leber's Congenital Amaurosis
- Central Progressive Vision Loss
- Chronic Progressive Conditions
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6652
- owl#annotatedSource
- t384046
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0112142
- core#notation
- DOID:0112142
- oboInOwl#hasDbXref
- MIM:618345
- IAO_0000115
- A retinitis pigmentosa that has_material_basis_in homozygous or compound heterozygous mutation in AHR on chromosome 7p21.1.
- rdf-schema#label
- retinitis pigmentosa 85
- oboInOwl#hasExactSynonym
- RP85
- rdf-schema#subClassOf
- t384124
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.